Valuation: Scinai Immunotherapeutics Ltd.

Market Cap 1.08M 937K 875K 804K 1.52M 103M 1.53M 10.28M 4.03M 51.41M 4.06M 3.97M 171M P/E 2024 *
-
P/E 2025 -0.2x
Enterprise Value 1.69M 1.46M 1.37M 1.25M 2.37M 161M 2.39M 16.05M 6.28M 80.22M 6.34M 6.2M 266M EV / Sales 2024
4,521,684x
EV / Sales 2025 2,346,088x
Free-Float
0.36%
Yield 2024 *
-
Yield 2025 -
1 day-8.35%
1 week+1.38%
Current month-8.35%
1 month-7.47%
3 months-64.76%
6 months-75.23%
Current year-64.86%
1 week 0.23
Extreme 0.2302
0.38
1 month 0.21
Extreme 0.214701
0.38
Current year 0.21
Extreme 0.214701
1.12
1 year 0.21
Extreme 0.214701
1.97
3 years 0.21
Extreme 0.214701
13.9
5 years 0.21
Extreme 0.214701
349
10 years 0.21
Extreme 0.214701
6,199.99
Manager TitleAgeSince
Chief Executive Officer 51 02/03/2021
Director of Finance/CFO 55 01/01/2007
Chief Tech/Sci/R&D Officer - 01/01/2022
Director TitleAgeSince
Chairman 77 30/09/2019
Director/Board Member 64 24/03/2020
Director/Board Member 71 24/03/2020
Date Insider Type Main position Quantity % Market Cap.
1/1/23 A Other

Director

1,200,000 0.1606%
1/1/23 A Other

Director

4,000,000 0.5354%
1/1/23 A Other

Chief Financial Officer

880,000 0.1178%
Change 5-day change 1-year change 3-year change Capi.($)
-8.35%+1.38%-82.98%-98.13% 1.08M
-0.68%-0.54%-2.73%+13.55% 48.22B
+6.03%+2.87%+428.15%+506.65% 38.79B
-2.21%+7.03%+25.08%+5.51% 38.41B
+2.94%-0.89%+8.03%+56.94% 34.88B
+1.98%+3.97%+13.89%+40.90% 29.19B
+0.31%-2.42%+35.92%+122.86% 16B
+0.47%-3.48% - - 16.05B
+1.59%+2.84%+4.40%+16.88% 13.53B
-0.98%-7.07%-5.76%-37.52% 12.22B
Average -0.36%+0.51%+47.11%+69.74% 24.73B
Weighted average by Cap. +0.47%+0.21%+80.81%+109.98%

Financials

2024 2025
Net sales 0.66 0.57 0.53 0.49 0.93 62.75 0.93 6.26 2.45 31.29 2.47 2.42 103.83 1.31 1.14 1.06 0.97 1.84 125.03 1.86 12.47 4.88 62.34 4.92 4.81 206.86
Net income 4.8M 4.16M 3.88M 3.57M 6.74M 457M 6.8M 45.63M 17.86M 228M 18.01M 17.61M 757M -8.31M -7.2M -6.72M -6.18M -11.68M -792M -11.79M -79.03M -30.93M -395M -31.2M -30.51M -1.31B
Net Debt 122K 106K 98.75K 90.71K 172K 11.63M 173K 1.16M 454K 5.8M 458K 448K 19.25M 606K 526K 490K 451K 852K 57.79M 860K 5.77M 2.26M 28.82M 2.28M 2.23M 95.62M
Logo Scinai Immunotherapeutics Ltd.
Scinai Immunotherapeutics Ltd, formerly known as BiondVax Pharmaceuticals Ltd is an Israel-based biopharmaceutical company that is principally focused on developing, manufacturing, and commercializing medical products for the prevention and treatment of autoimmune and infectious diseases but also for other illnesses. The Company’s core focus is to develop NanoAbs for the treatment of various diseases such as COVID-19, psoriasis, and asthma. The Company's product NanoAb is based on alpaca-derived nanosized antibodies (NanoAbs), also known as VHH-antibodies. Additionally, the Company offers manufacturing facilities, aseptic fill and finish suites, laboratories, and experienced professionals for other research and development companies. Scinai Immunotherapeutics Ltd operates in Israel.
Employees
45
Date Price Change Volume
04/08/26 $0.2534 -7.18% 487,307
03/08/26 $0.2730 0.00% 4,884,862
31/07/26 $0.2730 -1.09% 123,861
30/07/26 $0.2760 +3.49% 96,221
29/07/26 $0.2667 +1.02% 67,383

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. SCNI Stock